UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000027404 |
|---|---|
| Receipt number | R000031382 |
| Scientific Title | A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery. |
| Date of disclosure of the study information | 2017/07/01 |
| Last modified on | 2017/08/29 16:05:23 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery.
Acronym
A cohort study of a novel ovarian CCC tumor marker
Scientific Title
A cohort study of the target protein as a novel tumor marker for patients with ovarian clear cell carcinoma befor or after surgery.
Scientific Title:Acronym
A cohort study of a novel ovarian CCC tumor marker
Region
| Japan |
Condition
Condition
Ovarian clear cell carcinoma
Classification by specialty
| Obstetrics and Gynecology |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
We examine complementarity and subsidiarity of the target protein and CA125 measurement at the time of the follow-up from pre to post-operation.
Basic objectives2
Others
Basic objectives -Others
Practical clinical use of the target protein as a novel serum tumor marker
Trial characteristics_1
Others
Trial characteristics_2
Others
Developmental phase
Assessment
Primary outcomes
Changes in serum levels of target protein and CA125 before and after surgery(every 1-3 month)
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Female
Key inclusion criteria
1. Patinets whose pre-treatment serum samples are obetained.
2.Patients who submitted the documment for written informed consent
Key exclusion criteria
1. Patients who are judged as being inappropriate for this study.
2. Patients during pregnancy
Target sample size
15
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Yusuke Kunimi |
Organization
Kochi Health Science Center
Division name
Gynecology
Zip code
Address
2125-1, Ike, Kochi-city, Kochi-pref
TEL
088-837-3000
yuusuke_kunimi@khsc.or.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Yusuke Kunimi |
Organization
Kochi Health Science Center
Division name
Gynecology
Zip code
Address
2125-1, Ike, Kochi-city, Kochi-pref
TEL
088-837-3000
Homepage URL
yuusuke_kunimi@khsc.or.jp
Sponsor or person
Institute
Kochi Health Science Center
Institute
Department
Personal name
Funding Source
Organization
Tosoh Corporation
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
高知医療センター（高知県）
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 07 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Enrolling by invitation
Date of protocol fixation
| 2017 | Year | 08 | Month | 29 | Day |
Date of IRB
Anticipated trial start date
| 2017 | Year | 09 | Month | 15 | Day |
Last follow-up date
| 2018 | Year | 07 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Samples will be analyzed accrodingly.
Management information
Registered date
| 2017 | Year | 05 | Month | 19 | Day |
Last modified on
| 2017 | Year | 08 | Month | 29 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000031382
